Ali, Ahmed A.
Azouz, Rasha A. M.
Hussein, Nahla A.
El-Shenawy, Reem
Helmy, Naiera M.
El-Abd, Yasmine S.
Tabll, Ashraf A.
Funding for this research was provided by:
National Research Centre Egypt
Article History
Received: 11 October 2024
Accepted: 12 December 2024
First Online: 18 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: All authors declare no financial competing interests. However, two patent applications (EG/P/2024/176 and EG/P/2024/568) have been submitted to the Egyptian Patent Office (EGPO, Cairo, Egypt) to secure the rights for the generated HCV4a-VLPs and HCV4a-HEK293T stable cell line. This action aims to protect the intellectual property of the authors and the interests of the STDF funding authority.